✓ You're confirmed. Your access to the R&D Tax-Free Licensing Revenue workshop replay is ready below.
Watch the full session with Rand Brenner and CPA Greg Pfeuffer. As you do, consider how much R&D your organization has spent — and how much of that spending could be generating credits while your IP generates royalties.
R&D tax credits and IP licensing work independently — but combined, they create a compounding financial advantage most businesses never fully exploit.
11 reasons R&D tax credits are one of the most powerful and underused financial tools available — from startups to Fortune 500 companies.
The specific criteria that determine what qualifies — and four insider strategies for maximizing eligible claims that most businesses and their accountants miss.
Manufacturing and production activities qualify for R&D credits in ways most businesses overlook — eight specific pathways with practical examples.
Employee compensation is often the largest qualifying expense — but only if structured and documented correctly. Three approaches covered in detail.
How to structure licensing programs that convert R&D output into royalty income — and how those royalties can be offset by your credits to become tax-free.
How companies use licensing revenue to fund the next generation of R&D — creating a self-reinforcing cycle of innovation, tax credits, and royalty income.
Include employee salaries, contractor costs, materials, testing, and software development. Many businesses discover they've been underestimating their qualifying expenses — and missing credits as a result.
Think about patents, proprietary processes, algorithms, formulations, software, and trade secrets. Each represents a potential licensing asset that could generate royalty income offset by your credits.
Many businesses that have claimed credits have still left money on the table by not capturing all qualifying activities. Prior-year claims can often be amended retroactively.
Consider what it would mean for your growth, R&D investment cycle, and financial runway if a meaningful portion of your licensing royalties were effectively offset by credits you're already entitled to.
Rand Brenner has structured and executed licensing programs across medical technology, consumer products, entertainment, and regulated industries. He developed licensing programs for Mighty Morphin Power Rangers and Batman, and is the author of Hidden Wealth: The Money Making Power of Licensing (2019). His work has appeared in the Licensing Journal and Intellectual Property Magazine.
Greg Pfeuffer is a Partner at Mueller Prost leading the Orange County office. He focuses on helping CEOs, CFOs, and accounting teams generate profit and cash flow — particularly through R&D tax incentives, credits, and savings strategies. He works with businesses across innovation-driven industries to identify and maximize their qualifying R&D credit opportunities. Every dollar his team recovers goes directly to the bottom line.